Cargando…

Recent Advances in the Understanding and Treatment of Multiple Myeloma

Detalles Bibliográficos
Autores principales:	Cook, Richard, Jagannath, Sundar, Schwartz, Rowena N., Vozniak, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2008
Materias:	Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437680/ http://dx.doi.org/10.18553/jmcp.2008.14.S7-A.1

Ejemplares similares

Current and Emerging Treatments for Multiple Myeloma
por: Schwartz, Rowena N., et al.
Publicado: (2008)

Recent progress in the treatment of multiple myeloma: updates and highlights from ASH 2008
por: Jagannath, Sundar
Publicado: (2009)

Recent advances in understanding multiple myeloma
por: Dhakal, Binod, et al.
Publicado: (2016)

Recent advances in OCT imaging of the lamina cribrosa
por: Sigal, Ian A, et al.
Publicado: (2014)

Recent Advances in the Treatment of Patients with Multiple Myeloma
por: Legarda, Mario A., et al.
Publicado: (2020)

Recent Advances on the Pathobiology and Treatment of Multiple Myeloma
por: Amodio, Nicola
Publicado: (2021)

Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma
por: Abramson, Hanley N.
Publicado: (2023)

Proteasome inhibition and its therapeutic potential in multiple myeloma
por: Chari, Ajai, et al.
Publicado: (2010)

Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
por: Libby, Edward, et al.
Publicado: (2020)

Recent Advances in Nanotherapeutics for Multiple Myeloma
por: Iannazzo, Daniela, et al.
Publicado: (2020)

Oncology Pharmacy Management and the Evolving Role of Managed Care: Recommendations for a Changing Environment with a Focus on Multiple Myeloma
por: Dunn, Jeffrey D., et al.
Publicado: (2012)

Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee
por: Kumar, Shaji, et al.
Publicado: (2022)

Recent advances in the treatment of multiple myeloma: a brief review
por: Bobin, Arthur, et al.
Publicado: (2022)

What Affects Treatment Underuse in Multiple Myeloma in the United States: A Qualitative Study
por: Cytryn, Rose, et al.
Publicado: (2023)

Recent Advances in the Management of Smoldering Multiple Myeloma
por: Madhira, Bhaskara Reddy, et al.
Publicado: (2020)

Recent advances in multiple myeloma: a Korean perspective
por: Hong, Junshik, et al.
Publicado: (2016)

Recent advances in understanding multiple sclerosis
por: Stys, Peter K., et al.
Publicado: (2019)

The outcomes of newly diagnosed elderly multiple myeloma patients treated at a single U.S. institution
por: Bonomo, Lauren, et al.
Publicado: (2016)

Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead
por: Syed, Khalid Ali, et al.
Publicado: (2020)

Enhancement of clonogenicity of human multiple myeloma by dendritic cells
por: Kukreja, Anjli, et al.
Publicado: (2006)

Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia
por: Frame, David, et al.
Publicado: (2007)

HIV surveillance in MENA: recent developments and results
por: Bozicevic, Ivana, et al.
Publicado: (2013)

Introduction: Multiple Myeloma
por: Cook, Richard
Publicado: (2008)

Pathophysiological Underpinnings of Multiple Myeloma Progression
por: Jagannath, Sungar
Publicado: (2008)

Celiac disease: Understandings in diagnostic, nutritional, and medicinal aspects
por: Ben Houmich, Taoufik, et al.
Publicado: (2021)

MET-11 Recent advances in targeted therapies and immunotherapy for metastatic brain tumors
por: Ando, Yuichi
Publicado: (2021)

CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma
por: Martino, Massimo, et al.
Publicado: (2021)

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
por: Sanchez, Larysa, et al.
Publicado: (2021)

Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye Disease
por: Smith, Terry J
Publicado: (2022)

Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma
por: Jagannath, Sundar, et al.
Publicado: (2023)

Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US
por: Jagannath, Sundar, et al.
Publicado: (2021)

Lung Volume Reduction in Advanced Emphysema
por: Hopkinson, Nicholas S
Publicado: (2017)

Recent advances in immunotherapy for B-cell non-Hodgkin lymphoma and multiple myeloma
por: Chavez, Julio C., et al.
Publicado: (2022)

Recent advances in the management of older adults with newly diagnosed multiple myeloma in Japan
por: Suzuki, Tomotaka, et al.
Publicado: (2022)

Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma
por: Micallef, Johann, et al.
Publicado: (2010)

Advances in the treatment of extramedullary disease in multiple myeloma
por: Li, Yating, et al.
Publicado: (2022)

Managed Approaches to Multiple Sclerosis in Special Populations
por: Sperandeo, Kara, et al.
Publicado: (2011)

MM-239: A Tertiary Center Experience of Multiple Myeloma Patients with COVID-19: Lessons Learned and the Path Forward
por: Wang, Bo, et al.
Publicado: (2020)

Asthma Management Guidelines: Updates, Advances, and New Options
por: Navarro, Robert P., et al.
Publicado: (2007)

AHRQ's Comparative Effectiveness Research on Premixed Insulin Analogues for Adults with Type 2 Diabetes: Understanding and Applying the Systematic Review Findings
por: Qayyum, Rehan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7icpkj0hssodnun3u99ph27nkb